A recent study has shown that the frequencies of CD226/TIGIT expressing CD4+ and CD8+ T cells were significantly higher in patients with pSS than in HCs and other rheumatic disease controls and they were associated with disease activity of pSS (14). This evidence concerns the gene CD226 and peeling skin syndrome.